Clinical Trial

PillSense for Suspected Upper Gastrointestinal Bleeding

Study acronym: BLEED
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 10, 2024 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the efficacy and safety of a novel blood sensing capsule (PillSense), to help emergency doctors better evaluate if patients have active upper digestive tract bleeding, to determine if they can be discharged safely. The PillSense System consists of the PillSense Capsule, a small single use capsule that is safe for human consumption and PillSense Receiver, an external real-time monitor for data display to detect the presence of bleeding in the upper digestive tract within 10 minutes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-12.
Status change: Not Yet Recruiting → Recruiting 2024-12-05
Trial Details
NCT Number NCT06500468
Lead Sponsor Tan Tock Seng Hospital
Collaborators: EnteraSense Limited
Conditions Bleeding Ugi
Enrollment 84 participants
Start Date 2024-07-18
Primary Completion 2026-01 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-10